Vilniaus psichoterapijos studija, MB - financials and debts
Company age: 10 y. 1 mo.
Vilniaus psichoterapijos studija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 44,935 | 89,801 | 83,762 | 125,501 | 157,553 | 179,622 | 175,836 | 214,101 |
| Profit before tax | -839 | 35,558 | 18,203 | -14,878 | 13,881 | -7,832 | 11,207 | -59 |
| Net profit | -839 | 33,780 | 17,293 | -14,878 | 13,881 | -7,832 | 9,882 | -2,113 |
| Equity | 1,564 | 37,122 | 21,545 | 6,667 | 20,548 | 16,717 | 27,925 | 27,864 |
| Liabilities | - | - | - | - | 2,182 | 14 | 14 | 14 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 2,463 | 44,342 | 27,252 | 14,547 | 22,730 | 16,731 | 27,939 | 27,878 |
| Total assets | 2,463 | 44,342 | 27,252 | 14,547 | 22,730 | 16,731 | 27,939 | 27,878 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 10,136 | 13,553 | 21,777 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +99.8% | -6.7% | +49.8% | +25.5% | +14.0% | -2.1% | +21.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -34.1% | 76.2% | 63.5% | -102.3% | 61.1% | -46.8% | 35.4% | -7.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -53.6% | 91.0% | 80.3% | -223.2% | 67.6% | -46.9% | 35.4% | -7.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.9% | 37.6% | 20.6% | -11.9% | 8.8% | -4.4% | 5.6% | -1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.9% | 39.6% | 21.7% | -11.9% | 8.8% | -4.4% | 6.4% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.1 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vilniaus psichoterapijos studija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-06 | 203.28 |
| 2026-09-01 | 2026-09-02 | 203.28 |
| 2026-08-26 | 2026-08-31 | 122.80 |
| 2026-08-23 | 2026-08-23 | 122.80 |
| 2026-08-19 | 2026-08-19 | 122.80 |
| 2026-08-16 | 2026-08-17 | 122.80 |
| 2026-08-01 | 2026-08-14 | 122.80 |
| 2026-07-01 | 2026-07-31 | 42.32 |
| 2026-01-01 | 2026-01-31 | 59.44 |
| 2023-10-03 | 2023-10-31 | 58.63 |
Vilniaus psichoterapijos studija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-01 | 2026-04-01 | 7.0 |
| 2025-10-30 | 2025-11-02 | 8.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vilniaus psichoterapijos studija, MB (code 304371486) is a Lithuanian small partnership operating in other human health activities n.e.c. In 2025, the company generated revenue of €214.1K, up 21.8% year on year and 19.2% above the 2023 level. Profitability weakened after a stronger 2024 result: net profit was €9.9K in 2024, compared with a loss of €7.8K in 2023, and then declined to a loss of €2.1K in 2025. The 2025 profit margin was -1.0%, indicating that revenue growth was not fully translated into earnings. Over the three-year period, revenue moved from €179.6K in 2023 to €175.8K in 2024 and then to €214.1K in 2025. Balance sheet figures remained stable in 2024 and 2025, with total assets and equity both at €27.9K and liabilities at only €14. This resulted in an equity ratio of 100.0%. Asset turnover stood at 7.68x, while ROE and ROA were both -7.6% in 2025.